The programme started with an overview of the course by Dr Girish Bhatt, course coordinator of the programme and highlighted how Indian Academy of pediatrics (IAP) ALS group has developed its own ...
A diagnosis of amyotrophic lateral sclerosis typically means a person will survive for only two or three years—but some people live a decade or more. Patients, and their physicians, could benefit from ...
John Goodson practiced medicine for almost 50 years at Massachusetts General Hospital in Boston. As a primary care physician, he saw thousands of patients and ailments, so when he struggled to raise ...
Amyotrophic Lateral Sclerosis, ALS, is a horrible disease. Last week in a reversal of a decision the FDA made just a few months ago, their external advisory board approved a “novel” drug for ALS. What ...
The Food and Drug Administration has opened the door to early approval for a new ALS drug treatment despite limited, though promising, evidence of its effectiveness. After completing two clinical ...
ALS is a rare, but fatal disease that affects the nerve cells and leads to paralysis of voluntary muscles and death. In a new study, researchers from Karolinska Institutet have discovered a way to ...
Researchers at the Weizmann Institute of Science have shown in mice that intestinal microbes, collectively termed the gut microbiome, may affect the course of amyotrophic lateral sclerosis (ALS), also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results